Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Prognostic Factors and Response to the Hypomethylating Agents in Hypocellular Myelodysplastic Syndromes: A Retrospective Study from the Korean Society of Hematology AML/MDS Working Party

Blood (2017) 130 (Supplement 1): 4257.

https://doi.org/10.1182/blood.V130.Suppl_1.4257.4257

Published: 2017

Journal Articles

A Retrospective Study to Evaluate the Survival Rates in R-CHOP Chemotherapy Followed by Autologous Stem Cell Transplantation for the Treatment of Diffuse Large B Cell Lymphoma

Mark H. Lee, MD., PhD., Sung-Yong Kim, MD.PhD., Inho Kim, MD, PhD, Seonyang Park, MD, PhD, Yeo-Kyeoung Kim, MD.PhD., Yang Soo Kim, MD.PhD., Ho Sup Lee, MD, Jeong-A Kim, MD.PhD., Jinny Park, MD.PhD., Seok Jin Kim, MD, PhD, Sung Kyu Park, MD.PhD., Byeong-Bae Park, MD.PhD., Hyeok Shim, MD.PhD., Hyeon Seok Eom, MD, Junglim Lee, MD

Blood (2012) 120 (21): 4517.

https://doi.org/10.1182/blood.V120.21.4517.4517

Published: 2012

Journal Articles

Hematologic Improvement with Iron Chelation using therapy Deferasirox in Patients with Aplastic Anemia: A Subgroup Analysis of KAMS0112 Prospective Study,

Blood (2011) 118 (21): 3424.

https://doi.org/10.1182/blood.V118.21.3424.3424

Published: 2011

Journal Articles

Matched Pair Analysis Comparing the Outcomes of Primary Breast and Nodal Diffuse Large B Cell Lymphoma In Patients Treated with R-Chop; Consortium for Improving Survival of Lymphoma (CISL) Study.

Ho-Young Yhim, Jae-Yong Kwak, Hye Jin Kang, Seok Jin Kim, MD, PhD, Won Seog Kim, Jin Seok Kim, Chul Won Choi, Hyeon Seok Eom, Jeong-A Kim, Jae Hoon Lee, MD, PhD, Jong Ho Won, Hyeok Shim, MD, Dae Ho Lee, Cheolwon Suh, MD

Blood (2010) 116 (21): 1790.

https://doi.org/10.1182/blood.V116.21.1790.1790

Published: 2010

Journal Articles

A Multi-Center, Open Label Study Evaluating the Efficacy of Iron Chelation Therapy with Deferasirox In Transfusional Iron Overload Patients with Myelodysplastic Syndromes or Aplastic Anemia Using Quantitative R 2 mri.

Yoo-Hong Min, Hyeoung Joon Kim, MD, PhD, Kyoo-Hyung Lee, M.D., PhD., Jae Hoon Lee, MD, PhD, Hee-Sook Park, Jin Seok Kim, Hyeok Shim, MD, Chu-Myung Seung, Chul Soo Kim, Jooseop Chung, MD, PhD, Myung Soo Hyun, Deog-Yeon Jo, MD, PhD, Chul Won Jung, Sang Kyun Sohn, Hwi-Joong Yoon, MD, PhD, Byung Soo Kim, Young-Don Joo, Chi-Young Park

Blood (2010) 116 (21): 1125.

https://doi.org/10.1182/blood.V116.21.1125.1125

Published: 2010

Journal Articles

Efficacy of ICT with Deferasirox in Transfusional Iron Overloaded Patients with MDS or AA.

Blood (2009) 114 (22): 3810.

https://doi.org/10.1182/blood.V114.22.3810.3810

Published: 2009

Journal Articles

Osteonecrosis of the Jaw in Multiple Myeloma Patients: Incidence and Characteristics in Korean Patients.

Hyo Jung Kim, M.D., Ph.D., Hyeok Shim, M.D., Eunkyung Park, M.D., Ph.D., Min Kyoung Kim, M.D., Seok Jin Kim, MD, PhD, Joon Seong Park, M.D., Ph.D., Jong-Ho Won, M.D., Ph.D., Chang-Ki Min, M.D., Ph.D., Jae Hoon Lee, M.D., Ph.D., Korean Multiple Myeloma Working Party, (KMMWP)

Blood (2009) 114 (22): 4956.

https://doi.org/10.1182/blood.V114.22.4956.4956

Published: 2009

Journal Articles

Improved Survival of Patients with Multiple Myeloma and the Impact of Transplantation and Novel Agents: An Analysis of the Korean Multiple Myeloma Working Party (KMMWP).

Blood (2009) 114 (22): 4881.

https://doi.org/10.1182/blood.V114.22.4881.4881

Published: 2009

Journal Articles

The Prognostic Impact of Fluorescent-in Situ Hybridization (FISH) and Conventional Karyotying in Korean Multiple Myeloma Patients: A Retrospective Multicenter Study.

Blood (2009) 114 (22): 4902.

https://doi.org/10.1182/blood.V114.22.4902.4902

Published: 2009

Journal Articles

A Multi-Center, Open Label Study Evaluating the Efficacy of Iron Chelation Therapy with Deferasirox in Transfusional Iron Overload Patients with Myelodysplastic Syndromes or Aplastic Anemia Using Quantitative R 2 MRI

Blood (2008) 112 (11): 3649.

https://doi.org/10.1182/blood.V112.11.3649.3649

Published: 2008

Journal Articles

Bortezomib, Doxorubicin and Dexamethasone (PAD) Combination Therapy Followed by Thalidomide and Dexamethasone (TD) as a Salvage Treatment for Relapsed Multiple Myeloma (MM): Preliminary Analysis of Efficacy and Safety.

Sung Sook Lee, Cheolwon Suh, Bong-Seog Kim, Jooseop Chung, Young-Don Joo, Hun-Mo Ryoo, Young Rok Do, Jong-Youl Jin, Hye Jin Kang, Gyeong-Won Lee, Moon Hee Lee, Hyeok Shim, Kihyun Kim, Sung-Soo Yoon, Ho Young Kim, Dong Soon Lee, Jae-Hoon Lee

Blood (2007) 110 (11): 2731.

https://doi.org/10.1182/blood.V110.11.2731.2731

Published: 2007

Journal Articles

Diagnostic Usefulness of JAK2 Mutation in Manistest or Latent Polycythemia Vera and Secondary Polycythemia.

Soo-Mee Bang, Eun Mi Nam, Jeong Yeal Ahn, Jae-Hoon Lee, Bong-Seog Kim, Seung-Hyun Nam, Hyun-Sook Chi, Young Uk Cho, Hyo Jung Kim, Dae Young Zang, Moo-Rim Park, Hyeok Shim, Jong Seok Lee, Jong-Ho Won, Doyeun Oh, Korean MPD Working Party

Blood (2006) 108 (11): 4901.

https://doi.org/10.1182/blood.V108.11.4901.4901

Published: 2006

Journal Articles

Durable Remission of Acute Panmyelosis with Myelofibrosis Following Reduced-Intensity Allogeneic Peripheral Blood Stem Cell Transplantation.

Moo-Rim Park, MD, Hyeok Shim, MD, Young-Jin Lee, MD

Blood (2005) 106 (11): 5305.

https://doi.org/10.1182/blood.V106.11.5305.5305

Published: 2005

Journal Articles

The Feasibility Study for Using FLT3/ITD as a Marker of the Minimal Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML) by Serial Analysis in Diagnosis, Remission and Relapse.

Yeo-Kyeoung Kim, Hee-Nam Kim, Il-Kwon Lee, Su-Mi Lee, Hyeok Shim, Moo-Rim Park, Kyeoung-Soo Park, Deok-Hwan Yang, Je-Jung Lee, Hyeoung-Joon Kim

Blood (2005) 106 (11): 4515.

https://doi.org/10.1182/blood.V106.11.4515.4515

Published: 2005

NARROW

Prognostic Factors and Response to the Hypomethylating Agents in Hypocellular Myelodysplastic Syndromes: A Retrospective Study from the Korean Society of Hematology AML/MDS Working Party

A Retrospective Study to Evaluate the Survival Rates in R-CHOP Chemotherapy Followed by Autologous Stem Cell Transplantation for the Treatment of Diffuse Large B Cell Lymphoma

Hematologic Improvement with Iron Chelation using therapy Deferasirox in Patients with Aplastic Anemia: A Subgroup Analysis of KAMS0112 Prospective Study,

Matched Pair Analysis Comparing the Outcomes of Primary Breast and Nodal Diffuse Large B Cell Lymphoma In Patients Treated with R-Chop; Consortium for Improving Survival of Lymphoma (CISL) Study.

A Multi-Center, Open Label Study Evaluating the Efficacy of Iron Chelation Therapy with Deferasirox In Transfusional Iron Overload Patients with Myelodysplastic Syndromes or Aplastic Anemia Using Quantitative R 2 mri.

Efficacy of ICT with Deferasirox in Transfusional Iron Overloaded Patients with MDS or AA.

Osteonecrosis of the Jaw in Multiple Myeloma Patients: Incidence and Characteristics in Korean Patients.

Improved Survival of Patients with Multiple Myeloma and the Impact of Transplantation and Novel Agents: An Analysis of the Korean Multiple Myeloma Working Party (KMMWP).

Clinical Features and Treatment Outcomes of Non-Hodgkin's Lymphoma with Breast Involvement; Multi-Institutional Analysis of 98 Patients in Korea.

The Prognostic Impact of Fluorescent-in Situ Hybridization (FISH) and Conventional Karyotying in Korean Multiple Myeloma Patients: A Retrospective Multicenter Study.

A Multi-Center, Open Label Study Evaluating the Efficacy of Iron Chelation Therapy with Deferasirox in Transfusional Iron Overload Patients with Myelodysplastic Syndromes or Aplastic Anemia Using Quantitative R 2 MRI

Bortezomib, Doxorubicin and Dexamethasone (PAD) Combination Therapy Followed by Thalidomide and Dexamethasone (TD) as a Salvage Treatment for Relapsed Multiple Myeloma (MM): Preliminary Analysis of Efficacy and Safety.

Diagnostic Usefulness of JAK2 Mutation in Manistest or Latent Polycythemia Vera and Secondary Polycythemia.

Durable Remission of Acute Panmyelosis with Myelofibrosis Following Reduced-Intensity Allogeneic Peripheral Blood Stem Cell Transplantation.

The Feasibility Study for Using FLT3/ITD as a Marker of the Minimal Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML) by Serial Analysis in Diagnosis, Remission and Relapse.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only